The Rs1h knockout mouse displays retinal features typical for X-linked juvenile retinoschisis (RS). Consequently, this mouse line represents an excellent model to study early molecular events in RS.
R etinoschisis (RS) is a recessively inherited retinal dystrophy with macular disease often resulting in early-onset vision loss. A hallmark of the disease is a limited splitting of the central retina typically presenting as a spoke-wheel pattern. 1 Peripheral schisis is seen in approximately 50% of affected males and is usually located in the inferior temporal quadrant. RS is caused by loss-of-function mutations in the RS1 gene on Xp22. 13 . 2 It encodes a 24-kDa protein, termed retinoschisin, which is mainly secreted from photoreceptors as a homooligomeric complex. [3] [4] [5] [6] [7] Retinoschisin is almost entirely composed of a highly conserved discoidin domain frequently found in a wide range of membrane and extracellular proteins and most likely mediating cell adhesion and cellular signaling processes. 8, 9 To study retinoschisin function, we have generated a genetargeted mouse line with a disruption of Rs1h, the murine orthologue of the human RS1 gene. 10 The knockout mouse appears to be an excellent disease model that closely resembles human disease. For example, hemizygous male mice reveal a characteristic "negative electroretinogram" and a highly disorganized retinal architecture with schisis cavities within the inner nuclear layer. This is accompanied by progressive loss of cone and rod photoreceptor cells. 10 Recently, we have shown that the photoreceptor degeneration is due to apoptosis, more specifically to the receptor mediated extrinsic pathway, with a major burst of dying cells around postnatal day 18. 11 To elucidate the molecular events that precede photoreceptor disease in the Rs1h knockout mouse, we applied DNAmicroarray-based mRNA profiling in retinal tissue of postnatal stages (P)7, 9, 11, and 14. Besides Rs1h, we identified several differentially expressed transcripts with a functional annotation to adhesion, cytoskeleton, vesicular trafficking, and immune response. Most of the genes in these groups are regulated before the onset of an appreciable expression of genes involved in apoptosis. Notably, many genes are implicated in microglia/glia activity and inflammatory processes. An upregulated expression of the early growth response gene 1 (Egr1) was found relatively early in the disease process at P9. This has further prompted us to investigate the role of Egr1 in RS disease by generating Rs1h Ϫ/Y /Egr1 Ϫ/Ϫ double-knockout mice.
MATERIALS AND METHODS

Animals
Animals were maintained in an air-conditioned environment on a 12-hour light-dark schedule at 20°C to 22°C, and had free access to food and water. The health of the animals was regularly monitored, and all procedures strictly adhered to the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research. The Egr1 ϩ/Ϫ mouse was purchased from Taconic (Ry, Denmark) and the Rs1h Ϫ/Y mouse has been described previously. 10 These mice were on a C57BL/6 background and backcrossed for 12 generations. 
RNA Isolation
Retinal tissue was isolated from eye bulbs and purified under the microscope from contaminating vitreous body and retinal pigment epithelium/choriocapillaris. Total RNA was extracted (RNeasy Mini Kit; Qiagen, Hilden, Germany).
Microarray Analysis and Statistical Data Evaluation
Generation of double-stranded cDNA, preparation and labeling of cRNA, hybridization to 430A 2.0 or 430 2.0 mouse genome arrays (Affymetrix, Santa Clara, CA), washing, and scanning were performed according to the protocol. Scanned images were analyzed (Microarray Suite version 5.0; Affymetrix), to generate report files for quality control. For data analysis, expression levels of single probes derived from Affymetrix CEL-files were evaluated (ChipInspector software; Genomatix GmbH, Munich, Germany). Previous annotations of the single oligonucleotide probes by Affymetrix were disregarded, together with the grouping of the probes in probe sets. The sequence of each single probe was mapped against the current genome annotation (Build 36; National Center for Biotechnology Information [NCBI], Bethesda, MD) and only probes with uniqueness in the genome were used for analysis. Furthermore, single nucleotide polymorphisms were accounted for. Thereafter, ratios of single probe signals were calculated and logarithmic transformation was performed. For normalization, a linear total-intensity normalization algorithm was used. Significantly regulated transcripts were discovered by a single sided permutated t-test with a false discovery rate (FDR) calculation using the significance analysis of microarray (SAM) algorithm. 12 Scores were calcu- Tables S1, S2, S3, and S4,  respectively (all Supplementary Tables are available online at http://www. iovs.org/cgi/content/full/48/2/891/DC1). To increase stringency, a 1.8 fold-change and a minimum signal intensity of 50 were selected as inclusion criteria (Table 1) . 13 Functional annotation of transcripts was performed on computer (BiblioSphere, Pathway Edition; Genomatix, Munich, Germany).
14 The microarray data set of this study is publicly available at the NCBI Gene Expression Omnibus (http://www.ncbi.nlm. nih.gov/geo/) through accession number GSE5581. 
Quantitative Real-Time RT-PCR Analysis
SDS Gel Electrophoresis and Western Blot Analysis
Retinal tissue was homogenized in buffer (PhosphoSafe; Novagen, Madison, WI). Quantitation of protein extracts was performed by a protein assay based on the Bradford method (Bio-Rad). Western blots were prepared after SDS-PAGE of 20 g protein and labeled with phospho-ERK 1/2 pAb (dilution 1:1.000; Sigma-Aldrich, Munich, Germany), ERK 1/2 pAb (dilution 1:2.000; Sigma-Aldrich), or ␤-actin mAb (dilution 1:60.000; Sigma-Aldrich). After the blots were washed in PBS/Tween-20, they were labeled with goat anti-rabbit and goat antimouse Ig-peroxidase (dilution 1:10.000; Calbiochem, La Jolla, CA) for detection by enhanced chemiluminescence (ECL).
Immunofluorescence Labeling and TUNEL-Assay
Immunofluorescence studies of retinal cryosections and TUNEL-staining of eye bulbs from Rs1h-deficient, Egr1-deficient (Taconic) or double-knockout mice (Rs1h Ϫ/Y /Egr1 ϩ/Ϫ and Rs1h Ϫ/Y /Egr1 Ϫ/Ϫ ) was performed exactly as described recently.
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RESULTS
Microarray Analysis
To study molecular events accompanying retinoschisin deficiency, we first analyzed gene expression in retinal tissues from Rs1h-knockout and wild-type mice at P7, P9, and P11. In wild-type animals, expression of Rs1h mRNA is detectable at P5 and reaches adult levels at P11 (data not shown). Retinal cRNAs from three Rs1h Ϫ/Y mice and three wild-type littermates at P7, P9, and P11 were hybridized to microarrays (Mouse Genome 430A 2.0 GeneChips; Affymetrix) detecting 14,000 annotated mouse genes. For a second round analysis of stage P14, cRNAs from six Rs1h-knockout mice and seven wild-type littermates were hybridized to microarrays (Mouse Genome 430 2.0 GeneChips; Affymetrix) covering more than 34,000 mouse genes.
Initial evaluation of single probe expression ratios with a false discovery rate (FDR) of 5% based on SAM analysis indicated differential expression of 55 genes on P7, 60 genes on Tables S1-S4 ). Based on own experience with previous microarray studies, 13 we next applied higher-stringency conditions selecting for genes with at least 1.8-fold expression changes and minimum signal intensities of 50 signal units. Thereafter, the number of significantly regulated genes was reduced to 17 for P7, 24 for P9, 27 for P11, and 41 for P14 (Table 1) . The top regulated genes apart from Rs1h were Tlr4 (4.0-fold) and Wasf3 (Ϫ2.5-fold) at P7, Ubqln2 (2.0-fold) and Ndrg3 (Ϫ4.2-fold) at P9, Crip3 (3.7-fold) and the unknown gene 4632413K17 (Ϫ3.0-fold) at P11, and Spp1 (4.3-fold) and Cryaa (Ϫ2.2-fold) at P14.
To characterize further the observed mRNA regulations, molecular function annotation of pathways was performed. As displayed in Figure 1 , grouping of genes into pathways with at least two entries recurring in the time course (colored segments) yielded the main categories cytoskeleton, adhesion, vesicular trafficking, immune response, and apoptosis. At P7, genes involved in adhesion and vesicular trafficking were prominent, whereas at later stages immune response and microglia/glia-specific genes were mainly detected. Genes regulated at several time points include the induced immune regulatory gene Tlr4 and the downregulated vesicular trafficking gene Sh3gl2 (Table 2 ). All commonly regulated transcripts were found at P11 and we therefore conclude that these molecular events represent initial as well as secondary changes related to Rs1h deficiency. The large number of upregulated genes at P14 related to immune response also indicates a significant involvement of microglia and glia cells in RS. Because transcription factors are of particular importance for regulatory responses, the upregulation of Egr1 was verified by qRT-PCR along with the immune response genes induced at P14 (Table 1 and Fig. 1 ). Six transcripts which are increased at P14, namely Spp1, Emp1, S100a6, Lgals3, Cxcl12, and Vim contain verified Egr1 binding sites in their regulatory regions, suggesting that early Egr1 expression could induce transcriptional waves at later time points.
Refined Expression Profiling by qRT-PCR and Immunohistochemistry
We next examined the upregulated transcripts at postnatal stages P7, P9, P11, P13, P15, P18, and P22 by qRT-PCR (Fig. 2) . Egr1 was significantly induced in the retinoschisin-deficient retina starting at P9 (P Ͻ 0.05), further upregulated at P11 and P13 (P Ͻ 0.001 and P Ͻ 0.05, respectively), unchanged at P15, and again strongly induced at P18 and P22 (Fig. 2a) . We then quantified mRNA levels of 1700063D05, a gene with an as yet unknown function (Fig. 2b) . Upregulation of 1700063D05 transcripts started in Rs1h knockout mice at P13 but showed a marked decline from P15 to P22. The expression profile 1 in Figure 2c subsumes the mRNA pattern of 10 upregulated genes identified in the DNA-microarray experiments at P14 including Spp1, Tyrobp, Clec7a, Cd68, Ccl6, Fcer1g, Lyzs, Mpeg1, Msr2, and Cd53 (Table 1 and Supplementary Table S4) comprising microglia-associated genes. There is a steady increase in gene expression starting between P11 and P13 with a maximum at P18 and a decline beyond this time point. Expression profile 2 (Fig. 2d) represents the expression pattern of five genes including S100a6, Cyp26a1, Tgm2, Tagln2, and Gfap revealing a sharp upregulation between P15 and P18 and elevated levels until P22.
We then sought to define precisely the chronological expression of microglia-associated genes exemplified by Cd68 and Clec7a in comparison with transcripts involved in the extrinsic pathway of apoptosis (Casp8 and Tnfrsf6). There was a steady increase of expression profile 1 transcripts beginning at P13 while apoptosis-related upregulation started not until (Fig. 3) . These data clearly indicate that microglia-related gene expression precedes expression of apoptosis-related transcripts in the retinoschisin-deficient retina by several days. To correlate mRNA profiles with protein expression, we performed immunohistochemistry on Rs1h knockout and wildtype retinal sections from three developmental stages (P14, P18, and P24). Anti-F4/80 was used as a marker of microglia activation, whereas the glial fibrillary acidic protein (Gfap) served as a stress indicator of retinal Müller glial cells. At P14, expression of Gfap (green) was similar in the retinoschisindeficient and the wild-type retina, whereas the activation marker F4/80 (red) indicated isolated microglia in the inner nuclear layer of the Rs1h Ϫ/Y retina (Fig. 4, left) . At P18 and P24 there was prominent labeling of the two marker proteins in the Rs1h-knockout tissue (Fig. 4 , middle and right) fully corroborating our qRT-PCR data (Figs. 2c, 2d, 3) .
Analysis of the Erk1/2 Pathway in the Retinoschisin-Deficient Retina
Our data demonstrate that upregulation of Egr1 at P9 may contribute to the pathogenesis of the retinoschisin-deficient Table 1 . 16, 17 We therefore analyzed the phosphorylation status of Erk1/2 in the Rs1h-deficient retina at stages P5, P7, P11, and P13 (Fig. 5) . Western blot analysis revealed a significant increase in Erk1/2 phosphorylation (p-Erk1/2) at P7, P11, and P13 but not at P5 in retinal extracts from retinoschisin-deficient versus wild-type mice (Fig. 5) .
Characterization of the Rs1h
؊/Y /Egr1
Double-Knockout Mouse
To investigate the role of Egr1 in RS, we generated doubleknockout mice deficient for both retinoschisin and Egr1. Histologic examination of retinal sections from double knockout mice at P18 and P24 showed pathologic manifestations typical for the single Rs1h knockout. 10 Furthermore, three knockout genotypes (Rs1h ϩ/Y /Egr Ϫ/Ϫ , Rs1h Ϫ/Y /Egr ϩ/Ϫ , and Rs1h Ϫ/Y / Egr Ϫ/Ϫ ) were analyzed at P18 and P24 for mRNA expression of the upregulated marker genes 1700063D05, Cd68, and Gfap (Figs. 6a-c) . qRT-PCR demonstrates a significant increase of all three transcripts in the Rs1h-deficient retina independent of the Egr1 genotype (Egr1 ϩ/Ϫ or Egr1 Ϫ/Ϫ ) similar to the data obtained for the Rs1h single knockout. This suggests that partial or full Egr1 deficiency does not prevent induction of microglia/glia activation markers in the Rs1h Ϫ/Y retina. We finally explored possible effects of Egr1-deficiency on the extrinsic apoptotic pathway and identified that the apoptosis markers Tnfrsf6 and Casp8 are upregulated in the retinoschisin-deficient retina, independent of Egr1 expression status (Egr1 ϩ/Ϫ or Egr1 Ϫ/Ϫ ; Figs. 6d, 6e). To further corroborate these findings, TUNEL assays were performed in retinal sections of the three genotypes Rs1h
and Rs1h
Ϫ/Y /Egr Ϫ/Ϫ at developmental stages P18 and P24. The number of apoptotic nuclei was significantly increased in Rs1h Ϫ/Y versus wild-type retinas, either on the Egr1 ϩ/Ϫ or the Egr1 Ϫ/Ϫ background (Fig. 7) . This suggests no direct link between transcriptional Egr1 upregulation and apoptotic events in the retinoschisin-deficient mouse.
DISCUSSION
In the present study, we performed microarray analysis and qRT-PCR in the Rs1h Ϫ/Y retina compared with wild-type. At P7, where Rs1h is normally present and where early events in pathogenesis are expected, transcripts for adhesion molecules, photoreceptor-specific proteins, cytoskeleton, and neuroprotective proteins were detected. Among these, Nell2 is a neuron-specific secreted glycoprotein protecting against oxygenglucose-deprivation-and ␤-amyloid-induced cell death, 18 whereas overexpression of the photoreceptor protein recov- and wild-type (wt) or for both conditions calculated by subtracting relative expression values of wt from ko. Error bars, SD. Statistical significance is given as *P Ͻ 0.05 or **P Ͻ 0.001 (Student's t-test). Experiments were performed with retinas from two different animals (four eyes) and each were performed in triplicate measurements. erin leads to photoreceptor degeneration. 19 The strongest upregulated gene at P7, Tlr4, is expressed in retinal pigment epithelium 20 and in activated microglia. 21 Furthermore, human TLR4 genetic variants are associated with age-related macular degeneration, 22 suggesting functional consequences of these aberrant transcript patterns.
We have identified 10 genes gradually increasing in expression starting at P11 (profile 1), a steep upregulation of 1700063D05 at P13, and induction of five genes in profile 2 (1700063D05, Cyp26a, S100a6, Tagln2, and Gfap) between P15 and P18. Notably, P14 is a time point where first histopathological features such as cystlike structures in the inner retina, disruption of the outer plexiform layer, and disorganization and displacement of retinal cells become apparent in Rs1h Ϫ/Y animals. 10 Although 1700063D05 is of unknown function, Cyp26a1 plays a role in retinoic acid metabolism, 23 S100a6 is functionally involved in cell cycle progression, 24, 25 and Tagln2 represents a marker of smooth muscle differentiation. 26 Whereas a correlation between RS and upregulation of transcripts 1700063D05, Cyp26a, S100a6, and Tagln2 may be challenging to reconcile, increased expression of the intermediate filament protein Gfap most likely represents a reactive response of Müller glia cells and astrocytes to the degenerative processes caused by the lack of retinoschisin. Accordingly, consistent upregulation of Gfap in other models of retinal injury has been reported, including glaucoma, 27, 28 retinal tear injury, 29 and diabetic retinopathy. 30 The expression data at time points P11 and P14 clearly implicate microglia-mediated processes in pathologic events of retinoschisin deficiency. Several genes are related to immune response and are expressed in microglia. Clec7a is a patternrecognition receptor detecting ␤-glucans from fungi and plants, resulting in inflammation 31, 32 and Fcer1g encodes the gamma chain of the IgE receptor CD23, which is important for allergic reactions. 33 Lysz is an inducible marker of phagocytosis expressed during microglia activation after neuronal injury. 34 The chemokine Ccl6 acts as mediator of astrocyte and microglia migration in vitro, 35 whereas the secreted phosphoprotein Spp1, participates in cellular attachment.
36 Egr1 induces the expression of inflammatory mediators such as TNF-␣ or macrophage inflammatory protein-2 (MIP-2). 16, 37, 38 Egr1, together with Tyrobp, also controls terminal differentiation and activation of macrophages. 39 -42 Several of these immune-regulatory genes (e.g., Spp1, Lysz, and C1qb) and the immediate early response gene Egr1 have also been associated with retinal disease in DNA-microarray approaches similar to those used in our study, such as analyses of ischemic injury and light-induced damage to the retina. [43] [44] [45] Egr1, which is upregulated at P9 is involved in a large number of cellular events ranging from mitogenesis, differentiation, cell protection and survival, pro-and antiapoptotic processes to macrophage differentiation. 40, 46 Although not unique to retinoschisin-deficiency, this suggests that Egr1 may act as a convergence point for multiple signaling cascades, which is also supported by our finding that the promoters of six commonly induced genes at P14 related to adhesion, immune response, and cytoskeleton contain verified Egr1-binding sites. It is therefore of great interest to identify further the events upstream and downstream of the initiation of Egr1 transcription. Toward this end, we analyzed the phosphorylation of the MAP Erk1/2 kinases and have found that this pathway was activated in the retinoschisin-deficient retina as early as P7. In mammalian cells, the MEK1/2/ERK signaling pathway plays a crucial role in immediate early gene (IEG) induction by directly activating IEG promoter-bound transcription factors such as Egr1. 47 Further studies are needed to determine Egr1-expressing cell types in the diseased retina and to analyze the gene activation cascade upstream of Egr1. So far, the mechanism coupling the extracellular membrane-associated retinoschisin to intracellular signaling remains elusive, but it may be relayed via an as yet unknown membrane receptor protein.
We were also interested in exploring downstream consequences of Egr1 activation. However, double-knockout mice deficient of both Rs1h and Egr1 were indistinguishable from Rs1h single-knockout mice, specifically with regard to retinal histology and expression profiles of microglia/glia-and apoptosis-related transcripts. Our experiments are in line with findings demonstrating that Egr1 Ϫ/Ϫ mice have no obvious defects in macrophage differentiation. 48, 49 However, data from an antisense strategy demonstrate that Egr1 is essential for cell growth and macrophage differentiation. 40, 50, 51 These controversial results may be explained by functional redundancy of remaining family members Egr2, Egr3, and Egr4 which are often coordinately regulated. 52 To further unravel the role of Egr1 in retinoschisin-deficiency, it may therefore be necessary to simultaneously target several Egr genes.
Commonly, programmed cell death is thought to activate microglia cells resulting in the clearance of dying cells, 53 although in some cases macrophage stimulation conversely has been demonstrated to trigger apoptosis. 54 -56 We recently reported that postnatal photoreceptor cell death in the Rs1h Ϫ/Y knockout mouse is due to extrinsic apoptosis at P18. 11 We . The analysis was done for two stages at P18 and P24, respectively. Expression of succinate dehydrogenase subunit A (Sdha) serves as control for cDNA integrity. Experiments were performed with retinas from two different animals (four eyes) and were performed in triplicate measurements.
Gehrig et al.
IOVS, February 2007, Vol. 48, No. 2 have now defined the relative time course of microglia-and apoptosis-related events in this model and show that the two events can be unambiguously separated. Whereas immunerelated genes are upregulated starting as early as P11, apoptosis-associated transcripts are increased in the Rs1h-deficient retina only after P16. We therefore conclude that microglia activation precedes the onset of apoptotic cell death and may even be involved in triggering apoptosis in the diseased retina. The goal of the study was to analyze molecular events caused by retinoschisin-deficiency in a mouse model for RS. Our findings indicate activation of the Erk1/2 pathway at P7 followed by an upregulation of transcription factor Egr1 at P9. Functional clustering highlights key pathways including adhesion, cytoskeleton, vesicular trafficking and glia-cell related immune responses. As apoptosis-related gene expression in the retinoschisin-deficient retina is not initiated before P16, we hypothesize that microglia/glia-mediated processes precede and may even cause events of programmed photoreceptor cell death. FIGURE 7. TUNEL nuclei count for postnatal stages P18 and P24 indicates that apoptosis in the outer nuclear layer (ONL) depends on the Rs1h genotype but not on the Egr1 genotype (**P Ͻ 0.001, Student's t-test). Each column represents the mean of apoptotic nuclei counted in three retinal sections from three animals at P18 and P24, respectively.
